WebFind the latest Ono Pharmaceutical Co., Ltd. (OPHLY) stock quote, history, news and other vital information to help you with your stock trading and investing. Web23 de mar. de 2024 · CAMBRIDGE, Mass. , March 23, 2024 /PRNewswire/ -- ONO PHARMA USA , INC., announced that its candidate, tirabrutinib (ONO-4059), a Bruton's tyrosine kinase inhibitor, was granted Orphan Drug Designation on March 21, 2024 by the U.S. Food and Drug Administration (FDA) for the treatment of patients with primary …
Equillium grants Ono Pharma an option to purchase rights to …
Web1 de fev. de 2024 · Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President, Representative Director, Gyo Sagara; 'ONO') announced today that it has agreed to transfer the manufacturing and marketing approval authorization (MMAA) for Kinedak tablets which ONO has retained, as from April 1st, 2024 to Alfresa Pharma Corporation (Osaka, Japan; … Web10 de abr. de 2024 · Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; 'Ono'), Bristol Myers Squibb Co. (New Jersey, USA; 'BMS'), and Dana-Farber Cancer Institute, Inc. (Massachusetts, USA; 'Dana-Farber') have entered into a global agreement to settle all disputes relating to the anti-PD-1/PD-L1 antibody patents … ireland cja
Career ONO PHARMA USA, INC.
Web31 de ago. de 2024 · CAMBRIDGE, Mass., Aug. 31, 2024 /PRNewswire/ -- ONO PHARMA USA, INC.(President and CEO, Kunihiko Ito, "OPUS") announces its organization and leadership team expansion to advance its clinical ... Web13 de abr. de 2024 · Year on year Ono Pharmaceutical Co Ltd grew revenues 16.84% from 309.28bn to 361.36bn while net income improved 6.75% from 75.43bn to 80.52bn. View … Web30 de out. de 2024 · On October 31, ONO PHARMACEUTICAL will report earnings from the Q2. Forecasts of 2 analysts expect earnings of $0.155 per share as opposed to earnings of $0.130 per share from the same quarter ... ireland civil records